Search Results 431-440 of 2413 for 2024embarking

1. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

   About this study. The purpose of this multicenter, double-blind, randomized, placebo-controlled study is to evaluate the safety and efficacy of emricasan in ...

2. Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma - Mayo Clinic

   About this study. This is a Phase Ib, open-label, multicenter, global study designed to assess the safety and tolerability of RO6870810 as monotherapy and ...

3. A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. A Study to Evaluate Surgeon’s Prediction of Flap Outcomes - Mayo Clinic

   The purpose of this study is to improve cost-efficiency of microsurgical reconstruction by using flap-monitoring devices only when the surgeon believes that the ...

5. A Study to Evaluate Estetrol to Treat Moderate-to-Severe Vasomotor Symptoms in Postmenopausal Women - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. A Study To Test How Effective Belumosudil Tablets Are For Treating Adult Participants With Chronic Lung Allograft Dysfunction (ROCKaspire) - Mayo Clinic

   About this study. The objective of this study is to investigate the efficacy and safety of belumosudil compared with placebo, both administered on top of ...

7. Detection Of Barrett’s Esophagus-High Grade Dysplasia And Esophageal Adenocarcinoma - Mayo Clinic

   Methylated DNA Markers (MDMs) and copy number alterations have been discovered and biologically validated in esophageal brushings and swallowed cell collection ...

8. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

   A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R ...

9. Nizubaglusta in Late-Infantile and Juvenile Forms of Niemann-Pick Type C Disease and GM1 Gangliosidosis or GM2 Gangliosidosis - Mayo Clinic

   The purpose of this study is to demonstrate superior efficacy on ataxic manifestations with oral nizubaglustat dosing compared with placebo when administered ...

10. Florida - Commencement - Mayo Clinic College of Medicine & Science

    Fredric Meyer, M.D.. Juanita Kious Waugh Executive Dean of Education, Mayo Clinic College of Medicine and Science. Dean, Mayo Clinic Alix School of Medicine.